Effect of an Infant Formula With Synbiotics in Infants Born Via Caesarean Section
- Conditions
- Gut Microbiota
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 486
- Registration Number
- NCT04991792
- Locations
- 🇧🇬
University multiprofile hospital for active treatment "Dr. Georgi Stranski" EAD, Pleven, Bulgaria
Safety of an Infant Formula With Hydrolysed Protein in Term Infants
- Conditions
- Growth
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-11-26
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 360
- Registration Number
- NCT04736082
- Locations
- 🇩🇪
Evangelisches Waldkrankenhaus Spandau, Berlin, Germany
Prevention of Allergic Diseases in Infants
- Conditions
- Atopic Diseases
- Interventions
- Other: Hydrolyzed FormulaOther: Control formula
- First Posted Date
- 2018-04-05
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 1170
- Registration Number
- NCT03489733
- Locations
- 🇧🇬
Second specialized obstetric and gynecological hospital for active treatment Sheinovo EAD, Sofia, Bulgaria
🇨🇿Nemocnice Strakonice, a.s., Strakonice, Czechia
🇫🇮Suomen Terveystalo Oy, Tampere, Finland
Atopic Dermatitis in Atopy Predisposed Infants
- Conditions
- Dermatitis, Atopic
- Interventions
- Other: standardized skin care regimen
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 160
- Registration Number
- NCT02906475
- Locations
- 🇩🇪
Charite Universitätsmedizin Berlin, Berlin, Germany
The Combiotic-Study
- Conditions
- Healthy Term Infants
- Interventions
- Dietary Supplement: Control formulaDietary Supplement: Synbiotic formula
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 540
- Registration Number
- NCT02221687
- Locations
- 🇫🇷
C.I.C pédiatrique - C.H.U. de Nantes - Hôpital Mère-Enfant, Nantes, Loire-Atlantique, France
🇫🇷Alain BATY, Laval, Mayenne, France
🇫🇷Christian DUROY, Laval, Mayenne, France
Evaluation of Safety and Efficacy of New Infant Formula in Infantile Colic
- Conditions
- Infantile Colic
- Interventions
- Other: intervention formula 2Other: control formulaOther: intervention formula 1
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 169
- Registration Number
- NCT01721850
- Locations
- 🇮🇹
Pediatric office, Turin, Piemonte, Italy
🇮🇹Pediatric Office, Volvera, Piemonte, Italy
Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up
- Conditions
- Disturbance of Growth
- Interventions
- Other: intervention formula 1Other: intervention formula 2Other: control formulaOther: intervention formula 3
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- HiPP GmbH & Co. Vertrieb KG
- Target Recruit Count
- 503
- Registration Number
- NCT01143233
- Locations
- 🇷🇸
KBC "Dr Dragiša Mišović Dedinje", Belgrade, Serbia
🇦🇹Universitätsklinik für Kinder- und Jugendheilkunde, Abt. Neonatologie, päd. Intensivmedizin und Neuropädiatrie, Wien, Austria
🇩🇪University Hospital Rostock, Rostock, Mecklenburg-Vorpommern, Germany